COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,736 Articles (22,502 medRxiv, 8,234 bioRxiv)

Most recent first Previous |  Page 254: Articles 2531-2540  | Next

Dynamic label-free analysis of SARS-CoV-2 infection reveals virus-induced subcellular remodeling.
Saunders, N., Monel, B., Cayet, N., Archetti, L., Moreno, H., Jeanne, A., Marguier, A., Wai, T., Schwartz, O., Frechin, M.
10.1101/2023.11.16.567378 — Posted: 2023-11-17
Human microbiota is a reservoir of SARS-CoV-2 advantageous mutations
Cao, B., Wang, X., Yin, W., Gao, Z., Xia, B.
10.1101/2023.11.16.567485 — Posted: 2023-11-17
Identification of mouse CD4+ T cell epitopes in SARS-CoV-2 BA.1 spike and nucleocapsid for use in peptide:MHCII tetramers
Bricio Moreno, L., Barreto de Albuquerque, J., Neary, J. M., Nguyen, T., Hastie, K. M., Landeras-Bueno, S., Hariharan, C., Nathan, A., Getz, M. A., Gayton, A. C., Khatri, A., Gaiha, G. D., Saphire, E. O., Luster, A. D., Moon, J. J.
10.1101/2023.11.16.566918 — Posted: 2023-11-17
The influence of cross-border mobility on the COVID-19 epidemic in Nordic countries
Shubin, M., Brustad, H. K., Midtbo, J. E., Gunther, F., Alessandretti, L., Ala-Nissila, T., Scalia Tomba, G., Kivela, M., Yat Hin Chan, L., Leskela, L.
10.1101/2023.11.15.23297934 — Posted: 2023-11-16
Potential Biases in Test-Negative Design Studies of COVID-19 Vaccine Effectiveness Arising from the Inclusion of Asymptomatic Individuals
Ortiz-Brizuela, E., Carabali, M., Jiang, C., Merckx, J., Talbot, D., Schnitzer, M. E.
10.1101/2023.11.16.23298633 — Posted: 2023-11-16
Portrait of Mental Health Identified by People with the Post-Covid Syndrome
Mayo, N. E., Hum, S., Matout, M., Fellows, L. K., Brouillette, M.-J.
10.1101/2023.11.15.23298598 — Posted: 2023-11-16
Gender inequalities in the disruption of long-term life satisfaction trajectories during the COVID-19 pandemic and the role of time use: evidence from the 1970 British birth cohort
Moreno-Agostino, D., Chanfreau, J., Knowles, G., Pelikh, A., Das-Munshi, J., Ploubidis, G. B.
10.1101/2023.11.15.23298585 — Posted: 2023-11-16
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure
Cao, Y., Yang, S., Yu, Y., Xu, Y., Jian, F., Song, W., Yisimayi, A., Wang, P., Wang, J., Liu, J., Yu, L., Niu, X., Wang, J., Wang, Y., Shao, F., Jin, R., Wang, Y.
10.1101/2023.11.13.566860 — Posted: 2023-11-16
Evolutionary arms race between SARS-CoV-2 and interferon signaling via dynamic interaction with autophagy.
Lee, J. S., Dittmar, M., Miller, J., Li, M., Ayyanathan, K., Ferretti, M. B., Hulahan, J., Whig, K., Etwebi, Z., Griesman, T., Schultz, D. C., Cherry, S.
10.1101/2023.11.13.566859 — Posted: 2023-11-16
The Impact of SIV-Induced Immunodeficiency on Clinical Manifestation, Immune Response, and Viral Dynamics in SARS-CoV-2 Coinfection
Melton, A., Rowe, L. A., Penney, T., Krzykwa, C., Goff, K., Scheuermann, S. E., Melton, H. J., Williams, K., Golden, N., Moore Green, K., Smith, B., Russell-Lodrigue, K., Dufour, J. P., Doyle-Meyers, L. A., Schiro, F., Aye, P. P., Lifson, J. D., Beddingfield, B. J., Blair, R. V., Bohm, R. P., Kolls, J. K., Rappaport, J., Hoxie, J. A., Maness, N. J.
10.1101/2023.11.15.567132 — Posted: 2023-11-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).